 Jennifer Stevens Lapsley
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 71 | 2022 | 247 | 24.110 |
Why?
| | Osteoarthritis, Knee | 38 | 2022 | 223 | 12.750 |
Why?
| | Recovery of Function | 40 | 2022 | 604 | 8.810 |
Why?
| | Muscle Strength | 35 | 2022 | 283 | 7.610 |
Why?
| | Quadriceps Muscle | 26 | 2022 | 101 | 7.020 |
Why?
| | Physical Therapy Modalities | 18 | 2020 | 274 | 6.720 |
Why?
| | Knee Joint | 27 | 2022 | 353 | 5.740 |
Why?
| | Activities of Daily Living | 16 | 2022 | 354 | 4.940 |
Why?
| | Home Care Services | 9 | 2021 | 217 | 4.080 |
Why?
| | Arthroplasty, Replacement, Hip | 10 | 2022 | 111 | 4.070 |
Why?
| | Skilled Nursing Facilities | 5 | 2021 | 122 | 3.380 |
Why?
| | Exercise Therapy | 14 | 2020 | 355 | 3.200 |
Why?
| | Aged | 99 | 2022 | 19657 | 3.130 |
Why?
| | Muscle, Skeletal | 33 | 2022 | 1515 | 2.970 |
Why?
| | Range of Motion, Articular | 22 | 2022 | 369 | 2.880 |
Why?
| | Lower Extremity | 10 | 2019 | 335 | 2.600 |
Why?
| | Hospitalization | 14 | 2022 | 1785 | 2.420 |
Why?
| | Mobility Limitation | 6 | 2020 | 62 | 2.370 |
Why?
| | Disability Evaluation | 11 | 2021 | 280 | 2.260 |
Why?
| | Resistance Training | 8 | 2022 | 120 | 2.250 |
Why?
| | Patient Discharge | 11 | 2022 | 796 | 2.190 |
Why?
| | Subacute Care | 6 | 2021 | 74 | 2.140 |
Why?
| | Osteoarthritis, Hip | 5 | 2021 | 45 | 2.050 |
Why?
| | Exercise Test | 12 | 2019 | 551 | 2.000 |
Why?
| | Patient Readmission | 6 | 2021 | 634 | 1.940 |
Why?
| | Middle Aged | 76 | 2022 | 27617 | 1.850 |
Why?
| | Walking | 15 | 2020 | 415 | 1.780 |
Why?
| | Male | 103 | 2022 | 57801 | 1.780 |
Why?
| | Muscle Weakness | 9 | 2019 | 82 | 1.760 |
Why?
| | Female | 107 | 2022 | 61564 | 1.730 |
Why?
| | Gait | 9 | 2020 | 253 | 1.710 |
Why?
| | Medicare | 9 | 2022 | 663 | 1.710 |
Why?
| | Humans | 149 | 2022 | 118972 | 1.700 |
Why?
| | Aged, 80 and over | 33 | 2022 | 6561 | 1.670 |
Why?
| | Isometric Contraction | 17 | 2019 | 155 | 1.580 |
Why?
| | Spinal Cord Injuries | 7 | 2021 | 184 | 1.550 |
Why?
| | Walking Speed | 4 | 2022 | 35 | 1.540 |
Why?
| | Physical Therapists | 4 | 2020 | 36 | 1.520 |
Why?
| | Muscular Atrophy | 10 | 2022 | 80 | 1.510 |
Why?
| | Edema | 4 | 2022 | 124 | 1.500 |
Why?
| | Professional Role | 4 | 2019 | 153 | 1.380 |
Why?
| | Electric Impedance | 2 | 2019 | 101 | 1.340 |
Why?
| | Pain Measurement | 10 | 2021 | 469 | 1.330 |
Why?
| | Pyramidal Tracts | 2 | 2021 | 20 | 1.320 |
Why?
| | Frailty | 3 | 2022 | 116 | 1.300 |
Why?
| | Biofeedback, Psychology | 2 | 2020 | 24 | 1.260 |
Why?
| | Exercise | 14 | 2022 | 1657 | 1.220 |
Why?
| | Transitional Care | 2 | 2019 | 38 | 1.200 |
Why?
| | Walk Test | 6 | 2021 | 49 | 1.190 |
Why?
| | Postoperative Complications | 9 | 2019 | 2235 | 1.180 |
Why?
| | Joint Diseases | 2 | 2017 | 62 | 1.150 |
Why?
| | Dementia | 2 | 2020 | 208 | 1.140 |
Why?
| | Movement | 5 | 2020 | 248 | 1.110 |
Why?
| | Torque | 9 | 2017 | 67 | 1.090 |
Why?
| | Electric Stimulation Therapy | 6 | 2022 | 74 | 1.070 |
Why?
| | Weight-Bearing | 7 | 2017 | 172 | 1.060 |
Why?
| | Postoperative Period | 9 | 2021 | 309 | 1.050 |
Why?
| | Immobilization | 5 | 2010 | 47 | 1.040 |
Why?
| | Fee-for-Service Plans | 3 | 2020 | 79 | 1.040 |
Why?
| | Electric Stimulation | 7 | 2022 | 268 | 1.040 |
Why?
| | Treatment Outcome | 23 | 2022 | 9342 | 1.030 |
Why?
| | Aftercare | 3 | 2022 | 194 | 0.970 |
Why?
| | Rehabilitation | 2 | 2021 | 15 | 0.960 |
Why?
| | Geriatric Assessment | 3 | 2020 | 185 | 0.940 |
Why?
| | Prospective Studies | 21 | 2022 | 6471 | 0.920 |
Why?
| | Muscle Contraction | 12 | 2022 | 413 | 0.900 |
Why?
| | Frail Elderly | 3 | 2020 | 107 | 0.900 |
Why?
| | Amputees | 3 | 2018 | 62 | 0.870 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1244 | 0.820 |
Why?
| | Self Report | 5 | 2021 | 699 | 0.800 |
Why?
| | Leg | 7 | 2016 | 234 | 0.790 |
Why?
| | Health Services for the Aged | 2 | 2019 | 71 | 0.790 |
Why?
| | Veterans | 5 | 2020 | 1208 | 0.790 |
Why?
| | Systems Analysis | 1 | 2020 | 23 | 0.770 |
Why?
| | Cross-Sectional Studies | 16 | 2021 | 4552 | 0.770 |
Why?
| | Retrospective Studies | 18 | 2022 | 12978 | 0.760 |
Why?
| | Comorbidity | 4 | 2020 | 1527 | 0.760 |
Why?
| | Single-Blind Method | 6 | 2020 | 269 | 0.750 |
Why?
| | Health Care Reform | 1 | 2021 | 95 | 0.730 |
Why?
| | Hip Fractures | 1 | 2021 | 79 | 0.720 |
Why?
| | Pain | 7 | 2021 | 735 | 0.720 |
Why?
| | Hip Joint | 4 | 2019 | 144 | 0.710 |
Why?
| | Longitudinal Studies | 9 | 2022 | 2513 | 0.710 |
Why?
| | Arthroplasty, Replacement | 1 | 2020 | 47 | 0.700 |
Why?
| | Muscle Strength Dynamometer | 6 | 2020 | 22 | 0.690 |
Why?
| | Thigh | 5 | 2012 | 56 | 0.670 |
Why?
| | Muscle Fibers, Skeletal | 5 | 2022 | 192 | 0.660 |
Why?
| | Case-Control Studies | 13 | 2015 | 3171 | 0.650 |
Why?
| | Pain, Postoperative | 2 | 2019 | 211 | 0.650 |
Why?
| | Fatigue | 3 | 2019 | 297 | 0.630 |
Why?
| | Patient Transfer | 1 | 2019 | 143 | 0.610 |
Why?
| | High-Intensity Interval Training | 1 | 2017 | 18 | 0.610 |
Why?
| | Testosterone | 1 | 2021 | 351 | 0.610 |
Why?
| | Bone Malalignment | 1 | 2017 | 14 | 0.610 |
Why?
| | Accelerometry | 3 | 2019 | 72 | 0.590 |
Why?
| | Delivery of Health Care | 2 | 2021 | 867 | 0.580 |
Why?
| | Quality Improvement | 3 | 2021 | 963 | 0.570 |
Why?
| | Health Behavior | 3 | 2019 | 720 | 0.550 |
Why?
| | Self-Management | 1 | 2018 | 136 | 0.550 |
Why?
| | Homebound Persons | 1 | 2015 | 4 | 0.550 |
Why?
| | Knee Prosthesis | 1 | 2015 | 15 | 0.550 |
Why?
| | Behavior Therapy | 1 | 2018 | 237 | 0.550 |
Why?
| | Ankle Injuries | 3 | 2006 | 74 | 0.550 |
Why?
| | Tourniquets | 1 | 2016 | 27 | 0.540 |
Why?
| | Telemedicine | 3 | 2022 | 664 | 0.530 |
Why?
| | Telerehabilitation | 3 | 2022 | 26 | 0.520 |
Why?
| | United States | 13 | 2022 | 12555 | 0.520 |
Why?
| | Patient Care Planning | 1 | 2016 | 143 | 0.520 |
Why?
| | Physical Conditioning, Human | 1 | 2015 | 28 | 0.520 |
Why?
| | Biomechanical Phenomena | 6 | 2018 | 683 | 0.510 |
Why?
| | Evoked Potentials, Motor | 1 | 2014 | 37 | 0.500 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2012 | 158 | 0.500 |
Why?
| | Peripheral Vascular Diseases | 1 | 2015 | 98 | 0.490 |
Why?
| | Motor Cortex | 1 | 2014 | 52 | 0.490 |
Why?
| | Phenotype | 3 | 2021 | 3003 | 0.490 |
Why?
| | Electromyography | 6 | 2014 | 326 | 0.490 |
Why?
| | Community Health Services | 1 | 2016 | 212 | 0.480 |
Why?
| | Artificial Limbs | 2 | 2018 | 116 | 0.480 |
Why?
| | Physical Endurance | 1 | 2015 | 231 | 0.470 |
Why?
| | Musculoskeletal Pain | 1 | 2013 | 22 | 0.470 |
Why?
| | Models, Biological | 3 | 2021 | 1715 | 0.470 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 122 | 0.460 |
Why?
| | Arthralgia | 1 | 2013 | 51 | 0.450 |
Why?
| | Tendons | 1 | 2014 | 137 | 0.450 |
Why?
| | Restless Legs Syndrome | 1 | 2012 | 19 | 0.450 |
Why?
| | Time Factors | 10 | 2021 | 6412 | 0.440 |
Why?
| | Public Health | 1 | 2017 | 450 | 0.420 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2010 | 287 | 0.400 |
Why?
| | Risk Factors | 9 | 2021 | 9000 | 0.400 |
Why?
| | Time-to-Treatment | 1 | 2012 | 149 | 0.390 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 942 | 0.390 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2010 | 15 | 0.380 |
Why?
| | Fractures, Bone | 2 | 2006 | 380 | 0.370 |
Why?
| | Occupational Therapy | 2 | 2022 | 73 | 0.370 |
Why?
| | Cohort Studies | 6 | 2020 | 5116 | 0.350 |
Why?
| | Mobile Applications | 2 | 2022 | 147 | 0.340 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 21 | 0.340 |
Why?
| | Linear Models | 4 | 2019 | 827 | 0.330 |
Why?
| | Nursing Homes | 2 | 2020 | 130 | 0.330 |
Why?
| | Patient Participation | 3 | 2021 | 369 | 0.330 |
Why?
| | Quality of Life | 6 | 2022 | 2366 | 0.330 |
Why?
| | Colorado | 5 | 2019 | 4196 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 6 | 2021 | 3174 | 0.320 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4596 | 0.320 |
Why?
| | Qualitative Research | 3 | 2021 | 953 | 0.310 |
Why?
| | Age Factors | 5 | 2020 | 2995 | 0.310 |
Why?
| | Cancer Survivors | 2 | 2021 | 201 | 0.300 |
Why?
| | Adult | 20 | 2021 | 31512 | 0.300 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2874 | 0.300 |
Why?
| | Disabled Persons | 2 | 2019 | 147 | 0.290 |
Why?
| | Pilot Projects | 4 | 2022 | 1419 | 0.290 |
Why?
| | Absorptiometry, Photon | 2 | 2021 | 229 | 0.280 |
Why?
| | Muscle Fatigue | 3 | 2003 | 91 | 0.280 |
Why?
| | Running | 1 | 2008 | 227 | 0.280 |
Why?
| | Motor Activity | 4 | 2016 | 660 | 0.270 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 1868 | 0.260 |
Why?
| | Self Care | 2 | 2020 | 357 | 0.260 |
Why?
| | Tibia | 2 | 2018 | 177 | 0.260 |
Why?
| | Analysis of Variance | 3 | 2019 | 1293 | 0.260 |
Why?
| | Lipid Metabolism | 1 | 2008 | 477 | 0.250 |
Why?
| | Patient Satisfaction | 3 | 2020 | 610 | 0.250 |
Why?
| | Regression Analysis | 4 | 2012 | 983 | 0.240 |
Why?
| | Blood Loss, Surgical | 2 | 2016 | 87 | 0.240 |
Why?
| | Adipose Tissue | 1 | 2008 | 606 | 0.240 |
Why?
| | Aging | 2 | 2003 | 1670 | 0.220 |
Why?
| | Clinical Trials as Topic | 2 | 2018 | 969 | 0.220 |
Why?
| | Preoperative Care | 4 | 2020 | 332 | 0.210 |
Why?
| | Preoperative Period | 2 | 2014 | 110 | 0.210 |
Why?
| | Muscular Diseases | 1 | 2003 | 107 | 0.210 |
Why?
| | Body Mass Index | 1 | 2009 | 2092 | 0.210 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 1 | 2001 | 18 | 0.200 |
Why?
| | Torso | 1 | 2021 | 30 | 0.200 |
Why?
| | Phosphates | 3 | 2008 | 167 | 0.200 |
Why?
| | Leisure Activities | 1 | 2021 | 27 | 0.200 |
Why?
| | Patient Compliance | 3 | 2020 | 537 | 0.190 |
Why?
| | Administration, Topical | 1 | 2021 | 141 | 0.190 |
Why?
| | Communicable Disease Control | 1 | 2021 | 72 | 0.190 |
Why?
| | Anesthetics, Local | 2 | 2012 | 85 | 0.190 |
Why?
| | Radiography | 2 | 2013 | 861 | 0.190 |
Why?
| | Mentoring | 1 | 2022 | 101 | 0.190 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 252 | 0.180 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 22 | 0.180 |
Why?
| | Delphi Technique | 1 | 2020 | 164 | 0.180 |
Why?
| | Cardiovascular Deconditioning | 1 | 2019 | 4 | 0.180 |
Why?
| | Insurance Claim Review | 1 | 2020 | 67 | 0.180 |
Why?
| | Stakeholder Participation | 1 | 2020 | 69 | 0.180 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 33 | 0.180 |
Why?
| | Dependent Ambulation | 2 | 2019 | 9 | 0.180 |
Why?
| | Nociception | 1 | 2019 | 17 | 0.180 |
Why?
| | Androgens | 1 | 2021 | 167 | 0.180 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.170 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 37 | 0.170 |
Why?
| | Delaware | 1 | 2018 | 3 | 0.170 |
Why?
| | Focus Groups | 1 | 2021 | 387 | 0.170 |
Why?
| | Independent Living | 1 | 2020 | 86 | 0.170 |
Why?
| | Research Design | 3 | 2020 | 969 | 0.170 |
Why?
| | Postoperative Care | 1 | 2020 | 237 | 0.170 |
Why?
| | Rehabilitation Research | 1 | 2018 | 7 | 0.170 |
Why?
| | Hindlimb | 2 | 2010 | 137 | 0.170 |
Why?
| | Drainage | 1 | 2019 | 157 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 842 | 0.170 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2674 | 0.160 |
Why?
| | Bayes Theorem | 1 | 2020 | 344 | 0.160 |
Why?
| | Feasibility Studies | 4 | 2022 | 749 | 0.160 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2220 | 0.160 |
Why?
| | Ambulatory Care | 2 | 2019 | 482 | 0.160 |
Why?
| | Consensus | 1 | 2020 | 534 | 0.160 |
Why?
| | Physical Fitness | 2 | 2013 | 179 | 0.160 |
Why?
| | Physical and Rehabilitation Medicine | 1 | 2018 | 33 | 0.160 |
Why?
| | Patient Admission | 1 | 2019 | 176 | 0.150 |
Why?
| | Hamstring Muscles | 1 | 2017 | 17 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 254 | 0.150 |
Why?
| | Bone Density | 1 | 2021 | 449 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 271 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2018 | 262 | 0.140 |
Why?
| | Neuromuscular Diseases | 1 | 2017 | 90 | 0.140 |
Why?
| | Health Services Research | 1 | 2019 | 385 | 0.140 |
Why?
| | Patient Discharge Summaries | 1 | 2016 | 10 | 0.140 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 403 | 0.140 |
Why?
| | Risk | 1 | 2019 | 853 | 0.140 |
Why?
| | Likelihood Functions | 1 | 2016 | 136 | 0.140 |
Why?
| | Outpatients | 1 | 2019 | 325 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2174 | 0.130 |
Why?
| | Operative Time | 1 | 2016 | 114 | 0.130 |
Why?
| | Osteoarthritis | 1 | 2018 | 176 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 1125 | 0.130 |
Why?
| | Volition | 3 | 2008 | 33 | 0.130 |
Why?
| | Acceleration | 1 | 2015 | 31 | 0.130 |
Why?
| | Double-Blind Method | 1 | 2019 | 1687 | 0.130 |
Why?
| | ROC Curve | 2 | 2013 | 473 | 0.130 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.130 |
Why?
| | Appetite | 1 | 2015 | 57 | 0.130 |
Why?
| | Forecasting | 2 | 2018 | 353 | 0.130 |
Why?
| | Femoral Nerve | 2 | 2012 | 17 | 0.130 |
Why?
| | Pneumonia | 1 | 2020 | 592 | 0.130 |
Why?
| | Sex Factors | 2 | 2020 | 1781 | 0.130 |
Why?
| | Arthrometry, Articular | 1 | 2014 | 10 | 0.130 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 143 | 0.130 |
Why?
| | Critical Illness | 1 | 2020 | 662 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2020 | 497 | 0.120 |
Why?
| | Self Efficacy | 1 | 2018 | 366 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 483 | 0.120 |
Why?
| | Postural Balance | 2 | 2015 | 184 | 0.120 |
Why?
| | Syndrome | 1 | 2015 | 344 | 0.120 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2014 | 43 | 0.120 |
Why?
| | Documentation | 1 | 2016 | 175 | 0.120 |
Why?
| | Nerve Block | 2 | 2012 | 67 | 0.120 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 2 | 2010 | 22 | 0.120 |
Why?
| | Receptor, IGF Type 1 | 2 | 2010 | 59 | 0.120 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1166 | 0.120 |
Why?
| | Neural Inhibition | 1 | 2014 | 160 | 0.110 |
Why?
| | Logistic Models | 2 | 2021 | 1901 | 0.110 |
Why?
| | Ankle Joint | 3 | 2019 | 159 | 0.110 |
Why?
| | Traction | 1 | 2012 | 19 | 0.110 |
Why?
| | Prognosis | 3 | 2020 | 3443 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 91 | 0.110 |
Why?
| | Area Under Curve | 1 | 2013 | 296 | 0.110 |
Why?
| | Risk Assessment | 2 | 2020 | 3057 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2013 | 160 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1541 | 0.110 |
Why?
| | Physical Examination | 1 | 2014 | 243 | 0.110 |
Why?
| | Decision Trees | 1 | 2012 | 83 | 0.110 |
Why?
| | Repressor Proteins | 1 | 1995 | 377 | 0.100 |
Why?
| | Anthropometry | 1 | 2012 | 194 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2020 | 1798 | 0.100 |
Why?
| | Hospitals | 1 | 2016 | 598 | 0.100 |
Why?
| | Protons | 2 | 2008 | 79 | 0.100 |
Why?
| | Treatment Failure | 1 | 2012 | 341 | 0.100 |
Why?
| | Depression | 1 | 2019 | 1132 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2016 | 699 | 0.100 |
Why?
| | Torsion, Mechanical | 1 | 2010 | 7 | 0.100 |
Why?
| | Escherichia coli | 1 | 1995 | 758 | 0.100 |
Why?
| | Dependovirus | 1 | 2010 | 52 | 0.090 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 51 | 0.090 |
Why?
| | Communication | 1 | 2016 | 761 | 0.090 |
Why?
| | Anesthesia, Conduction | 1 | 2010 | 23 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2013 | 364 | 0.090 |
Why?
| | Random Allocation | 1 | 2010 | 344 | 0.090 |
Why?
| | Models, Theoretical | 1 | 2013 | 556 | 0.090 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 154 | 0.090 |
Why?
| | Chronic Disease | 1 | 2015 | 1636 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 1995 | 759 | 0.090 |
Why?
| | Hypertrophy | 2 | 2010 | 121 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2008 | 508 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 1995 | 1323 | 0.080 |
Why?
| | Cardiac Surgical Procedures | 1 | 2013 | 461 | 0.080 |
Why?
| | Confidence Intervals | 2 | 2021 | 324 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2010 | 219 | 0.080 |
Why?
| | Oxidative Stress | 1 | 1995 | 1178 | 0.080 |
Why?
| | Hindlimb Suspension | 1 | 2008 | 24 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 982 | 0.080 |
Why?
| | Physical Conditioning, Animal | 1 | 2010 | 204 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1346 | 0.080 |
Why?
| | Health Surveys | 1 | 2009 | 454 | 0.080 |
Why?
| | Paralysis | 1 | 2008 | 67 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4708 | 0.070 |
Why?
| | Transcription Factors | 1 | 1995 | 1570 | 0.070 |
Why?
| | Body Composition | 2 | 2008 | 653 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1691 | 0.070 |
Why?
| | Mental Health | 2 | 2022 | 568 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2013 | 972 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 2 | 2010 | 2478 | 0.060 |
Why?
| | Patient Safety | 2 | 2019 | 281 | 0.060 |
Why?
| | RNA | 1 | 2010 | 833 | 0.060 |
Why?
| | Preliminary Data | 1 | 2022 | 10 | 0.050 |
Why?
| | Rats | 2 | 2010 | 5392 | 0.050 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 44 | 0.050 |
Why?
| | Imaging, Three-Dimensional | 1 | 2004 | 499 | 0.050 |
Why?
| | Motion Therapy, Continuous Passive | 1 | 2020 | 1 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 4908 | 0.050 |
Why?
| | Cryotherapy | 1 | 2020 | 17 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 502 | 0.050 |
Why?
| | Peer Review | 1 | 2020 | 40 | 0.050 |
Why?
| | Animals | 4 | 2010 | 33381 | 0.050 |
Why?
| | Myalgia | 1 | 2019 | 15 | 0.040 |
Why?
| | Multiple Sclerosis | 1 | 2004 | 384 | 0.040 |
Why?
| | Pain Threshold | 1 | 2019 | 69 | 0.040 |
Why?
| | Knee | 1 | 2019 | 52 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 418 | 0.040 |
Why?
| | Confidentiality | 1 | 2019 | 67 | 0.040 |
Why?
| | Wearable Electronic Devices | 1 | 2019 | 34 | 0.040 |
Why?
| | Expert Testimony | 1 | 2018 | 56 | 0.040 |
Why?
| | Informed Consent | 1 | 2019 | 163 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 388 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 115 | 0.040 |
Why?
| | Hip | 1 | 2018 | 46 | 0.040 |
Why?
| | Self-Assessment | 1 | 2018 | 63 | 0.040 |
Why?
| | Reaction Time | 1 | 2019 | 392 | 0.040 |
Why?
| | Hip Prosthesis | 1 | 2018 | 33 | 0.040 |
Why?
| | Femur Head | 1 | 2018 | 41 | 0.040 |
Why?
| | Feedback | 1 | 2017 | 153 | 0.040 |
Why?
| | Psychometrics | 1 | 2020 | 631 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2018 | 204 | 0.040 |
Why?
| | Diabetic Angiopathies | 1 | 2019 | 260 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1129 | 0.040 |
Why?
| | Mice | 2 | 2010 | 15520 | 0.040 |
Why?
| | Obesity | 1 | 2009 | 2746 | 0.040 |
Why?
| | Amputation, Traumatic | 1 | 2016 | 18 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 726 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 635 | 0.030 |
Why?
| | Perception | 1 | 2018 | 314 | 0.030 |
Why?
| | Casts, Surgical | 2 | 2006 | 31 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 238 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2017 | 456 | 0.030 |
Why?
| | Decision Making | 1 | 2021 | 809 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 372 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2015 | 192 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1995 | 381 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1995 | 522 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 1995 | 314 | 0.030 |
Why?
| | Escherichia coli Proteins | 1 | 1995 | 170 | 0.030 |
Why?
| | Peripheral Arterial Disease | 1 | 2019 | 377 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 1995 | 279 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1995 | 653 | 0.030 |
Why?
| | Protein Conformation | 1 | 1995 | 848 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 1995 | 940 | 0.030 |
Why?
| | Biopsy | 1 | 2015 | 1079 | 0.030 |
Why?
| | Base Sequence | 1 | 1995 | 2159 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1995 | 2071 | 0.020 |
Why?
| | Anesthesia, Spinal | 1 | 2010 | 5 | 0.020 |
Why?
| | Anesthesia Recovery Period | 1 | 2010 | 10 | 0.020 |
Why?
| | Paired Box Transcription Factors | 1 | 2010 | 40 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1995 | 2871 | 0.020 |
Why?
| | Endpoint Determination | 1 | 2010 | 69 | 0.020 |
Why?
| | Amides | 1 | 2010 | 86 | 0.020 |
Why?
| | Muscle Development | 1 | 2010 | 102 | 0.020 |
Why?
| | Protein Binding | 1 | 1995 | 1975 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2010 | 380 | 0.020 |
Why?
| | Lung | 1 | 2021 | 3664 | 0.020 |
Why?
| | Regeneration | 1 | 2010 | 165 | 0.020 |
Why?
| | Phosphocreatine | 1 | 2008 | 37 | 0.020 |
Why?
| | Rest | 1 | 2008 | 104 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 405 | 0.020 |
Why?
| | Mitochondria, Muscle | 1 | 2008 | 97 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 439 | 0.020 |
Why?
| | Teaching | 1 | 2008 | 236 | 0.020 |
Why?
| | Inorganic Chemicals | 1 | 2004 | 2 | 0.020 |
Why?
| | Ischemia | 1 | 2008 | 374 | 0.020 |
Why?
| | Nutrition Assessment | 1 | 2004 | 78 | 0.020 |
Why?
| | Adolescent | 1 | 2003 | 18480 | 0.020 |
Why?
| | Phosphorylation | 1 | 2008 | 1633 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2004 | 443 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2010 | 2657 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3730 | 0.010 |
Why?
|
|
Stevens Lapsley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|